In Certain Types of Lung Cancer, Targeted Drug Tagrisso Slashed Recurrence Rates, New Study Says

Updated March 30th, 2022

In Certain Types of Lung Cancer, Targeted Drug Tagrisso Slashed Recurrence Rates, New Study Says

Already approved for EGFR-positive metastatic non-small cell lung cancer, osimertinib (Tagrisso ) brings major benefits in early cancer, too.

NOW
PLAYING
A Brave 11-Year-Old Girl is the First to Beat a Rare Cancer, Blowing the Minds of Her Medical Team with Groundbreaking New Treatment
NOW
PLAYING
Late Actress Bea Arthur Fondly Remembered: Cancer Warrior is Honored at 'Golden Girls' Convention
NOW
PLAYING
Understanding PI3K Inhibitors: How Can This Type of Targeted Therapy Treat CLL?
NOW
PLAYING
Brave Lung Cancer Survivor & Matriarch of ‘Alaskan Bush People’ Family Ami Brown’s Request to Dismiss Federal $500K Lawsuit Against Husband’s Estate is Denied
NOW
PLAYING
How Does Atezolizumab (Tecentriq) Treat Lung Cancer?
NOW
PLAYING
How is Melanoma Treated After Surgery?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.